Quality Assurance/Quality Control Plan Sample Clauses

Quality Assurance/Quality Control Plan. All quality control procedures for materials and workmanship will be in accordance with the contract provisions and Construction Manual. Quality Assurance Control Matrix Items QA/QC item Lead Standard(s) or References Project Materials Files Xxxxx Xxxxxx Initial ROM HQ Materials Lab CM 9-1.5A ROM Maintenance Xxxxx Xxxxxx/Xxxx Xxxx CM 9-1.5A Tester Qualification Xxxxx Xxxxxxx Acceptance Sampling As assigned CM 9-4, and Special Provisions Field Acceptance and Testing As assigned CM 9-4, and Special Provisions Lab Acceptance Testing Region Materials Lab CM 9-4, and Special Provisions Source Approval Varies CM 9-1.5B Xxxx Xxxxxxx Field Verification of Materials Xxxx Xxxxxx CM 9-1.5C Xxxx Xxxxxxx Others as Necessary WZTC Review (If Applicable) Xxxxxxx Xxxxxxxx Traffic Control Plans and MUTCD Maintenance Review Xxxxxx Xxxxxx IM 01.02 Management Review Xxxxx Xxxxxxxx Engineering Manager Region Compliance Review Xxxx Xxxxxx CM 10-5 Materials Certification Xxx Xxxxxx Project Communication Plan Facilitating action and making quality, timely project decisions is directly related to how well we communicate as a team. Effective communication requires sufficient, timely and accurate flow of information through the appropriate channels. The communication channels and protocol for various project activities are as follows: The project office staff is the primary contact for all project activities Area Codes are 509 unless stated otherwise. Prime Contractor: Xxxxxx Construction & Management, Inc. (Office) 534-1030 Traffic Control Contractor: Xxxxxx Construction & Management, Inc. Traffic Control Supervisor (TCS) Traffic Control Manager (TCM) 1st Contact: Xxxx Xxxxxxxx, TCM – Xxxxxx Construction (Cell) 000-0000 2nd Contact: Xxxxxxx Xxxxxxxx, TCS – Xxxxxx Construction (Cell) 000-0000 3rd Contact: TBA Prime Contractor: Xxxxxx Construction Cell Office Project Manager (Interim): Xxxx Xxxxxx 475-4680 534-1030 SPCC Lead: Xxxx Xxxxxxxx 939-9464 534-1030 TESC Lead: Xxxx Xxxxxxxx 939-9464 534-1030 Project Superintendent: Xxxx Xxxxxxxx 939-9464 534-1030 WSDOT: Xxx Xxxxxx, Project Engineer Cell Home Office Project Inspector (Civil): Xxxx Xxxxxxx 939-4250 324-6237 Project Inspector (Structures): Xxxx Xxxxxx 993-3548 324-6236 Project Inspector (Structures): Xxxx Xxxxxxx 939-1822 324-6240 Project Manager: Xxxxxxxx Xxxxx 590-3732 487-4584 324-6235 Assistant Project Engineer: Xxxx Xxxxx 209-7552 466-4368 324-6238 Project Engineer: Xxx Xxxxxx 220-5347 467-6991 324-6232 Spokane Maintenance: ...
Sample 1
AutoNDA by SimpleDocs
Quality Assurance/Quality Control Plan. The GEC shall update and maintain the existing program Quality Assurance / Quality Control (QA/QC) Plan to document the quality control program to be implemented by the project team. The GEC shall conduct Quality Control procedures under respective work tasks and sub-tasks. The GEC shall perform quarterly quality audits to ensure the QA/QC Plan is being implemented by the project team. The GEC shall conduct spot-check reviews to verify that the GEC team and others are submitting QC documentation and complete redlines by product (including milestones for design products). The GEC shall schedule and work with GEC Project and Subject Matter Leads to facilitate the completion of provider evaluation forms and documentation as needed to support the evaluations, at a general timing of at least every milestone submittal for design products and quarterly for non-design products. The GEC shall report upon the program’s progress in quality tracking and enforcement, schedule enforcement as documented in the provider evaluations, as well as proposed strategies for improvement in quality and schedule adherence at the GEC Quarterly Status Report. DocuSign Envelope ID: 3FC526E5-7650-4F1C-BCF1-67484E873D0D Deliverables
Sample 1
Quality Assurance/Quality Control Plan. The GEC shall update and maintain the existing program Quality Assurance / Quality Control (QA/QC) Plan to document the quality control program to be implemented by the project team. The GEC shall conduct Quality Control procedures under respective work tasks and sub-tasks. The GEC shall perform bi-annual quality audits to ensure the QA/QC Plan is being implemented by the project team. The GEC shall conduct spot-check reviews to verify that the GEC team and others are submitting QC documentation and complete redlines by product (including milestones for design products). The GEC shall schedule and work with GEC Project and Subject Matter Leads to facilitate the completion of provider evaluation forms (as requested by TxDOT) and documentation as needed to support the evaluations, at a general timing of at least every milestone submittal for design products and quarterly for non-design products. The GEC shall report upon the program’s quality and enforcement in a quality briefing. DocuSign Envelope ID: CD7AC889-92AB-43FB-B747-828C4DC6138B Contract No. 14-6SDP5028 PS No. 6519 Supplemental Agreement No. 3 Deliverables 145.2.a Updates (as necessary) to GEC QA/QC Plan in electronic format, accessible to STATE and sub-consultants 145.2.b Bi-annual GEC quality audits and documentation of QA/QC implementation 145.2.c PDE Redlines Spot Check Log and Documentation 145.2.d PDE Provider Evaluation Log 145.2.e GEC and PDE Quality Status Summary and Recommendations Briefing
Sample 1
Quality Assurance/Quality Control Plan. 2.20.1 Implementation of Quality Assurance Plan. Attached as Appendix R is a quality assurance/quality control procedure and plan and Supplier source inspection plan detailing Contractor’s system, including quality plans and procedures, to direct and control its organization with regard to quality (the “Quality Assurance Plan”). Contractor’s Quality Assurance Plan as set forth in Appendix R shall be consistent with Applicable Laws, ISO 9001 criteria, Applicable Codes and Standards and GECP. Contractor shall perform the Work in compliance with the Quality Assurance Plan and assume all costs associated with compliance therewith. Contractor shall cause each of its Suppliers to implement a quality assurance program that complies with the Quality Assurance Plan as applicable to the Work that such Supplier performs, including the implementation and maintenance of a rigorous inspection program, maintaining daily logs of inspections performed in compliance therewith, and the implementation and adherence to the “build it clean, build it tight” requirements of the Quality Assurance Plan.
Sample 1
Quality Assurance/Quality Control Plan 
Sample 1Sample 2

Related to Quality Assurance/Quality Control Plan

  • Quality Assurance The parties endorse the underlying principles of the Company’s Quality Management System, which seeks to ensure that its services are provided in a manner which best conforms to the requirements of the contract with its customer. This requires the Company to establish and maintain, implement, train and continuously improve its procedures and processes, and the employees to follow the procedures, document their compliance and participate in the improvement process. In particular, this will require employees to regularly and reliably fill out documentation and checklists to signify that work has been carried out in accordance with the customer’s specific requirements. Where necessary, training will be provided in these activities.

  • Quality Control A. Controlled Affiliate agrees to use the Licensed Marks and Name only in connection with the licensed services and further agrees to be bound by the conditions regarding quality control shown in attached Exhibit A as they may be amended by BCBSA from time-to-time.

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • REGULATORY ADMINISTRATION SERVICES BNY Mellon shall provide the following regulatory administration services for each Fund and Series:  Assist the Fund in responding to SEC examination requests by providing requested documents in the possession of BNY Mellon that are on the SEC examination request list and by making employees responsible for providing services available to regulatory authorities having jurisdiction over the performance of such services as may be required or reasonably requested by such regulatory authorities;  Assist with and/or coordinate such other filings, notices and regulatory matters and other due diligence requests or requests for proposal on such terms and conditions as BNY Mellon and the applicable Fund on behalf of itself and its Series may mutually agree upon in writing from time to time; and

  • Quality Control Procedures The Seller must have an internal quality control program that verifies, on a regular basis, the existence and accuracy of the legal documents, credit documents, property appraisals, and underwriting decisions. The program must be capable of evaluating and monitoring the overall quality of its loan production and servicing activities. The program is to ensure that the Mortgage Loans are originated and serviced in accordance with prudent mortgage banking practices and accounting principles; guard against dishonest, fraudulent, or negligent acts; and guard against errors and omissions by officers, employees, or other authorized persons.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Assistance and Cooperation After the Closing Date, each of Seller and Purchaser shall:

Time is Money Join Law Insider Premium to draft better contracts faster.